Pre-demographic dividend vs Slovakia: Immunization, measles second dose
Pre-demographic dividend
50.4%
in 2024
Slovakia
94.0%
in 2024
Pre-demographic dividend rank
42nd
Slovakia rank
40th
Immunization, measles second dose over time
- Pre-demographic dividend
- Slovakia
How they compare
Slovakia currently reports 94.0% against 50.4% in Pre-demographic dividend, a difference of 43.6%.
That makes Slovakia's figure about 1.9 times Pre-demographic dividend's.
Across all 25 years both countries report, Slovakia has been ahead every year.
Pre-demographic dividend ranks 42nd and Slovakia ranks 40th of 43 groups.
Slovakia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Pre-demographic dividend | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.3% | 98.7% | 96.4% | Slovakia |
| 2010s | 14.9% | 98.1% | 83.2% | Slovakia |
| 2020s | 40.9% | 95.8% | 54.9% | Slovakia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, Pre-demographic dividend or Slovakia?
- Slovakia, at 94.0% against 50.4% in Pre-demographic dividend as of 2024.
- What is the difference in immunization, measles second dose between Pre-demographic dividend and Slovakia?
- 43.6%, with Slovakia ahead.
- How many years of comparable data are there for Pre-demographic dividend and Slovakia?
- 25 years are reported by both, from 2000 to 2024.
- How do Pre-demographic dividend and Slovakia rank globally for immunization, measles second dose?
- Pre-demographic dividend ranks 42nd and Slovakia ranks 40th of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.